Dr Reddys Laboratories Ltd up for third straight session
NSE is in focus.
· Business Standard Mkts
Dr Reddys Laboratories Ltd is quoting at Rs 1243, up 1.8% on the day as on 12:49 IST on the NSE. The stock is up 1.58% in last one year as compared to a 7.89% slide in NIFTY and a 25.3% slide in the Nifty Pharma index.
The analysis
NSE reported Rs 1243,, with movement of 1.8%, 1.58% and 7.89% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
In this story
Related coverage
Stock Market Crash LIVE: Sensex Tanks Over 1,200 Points, Nifty 50 Below 22,200; ITC, JSW Steel, IndiGo Among Top Losers
INR vs USD: Rupee near 97/dollar; how TCS, Sun Pharma, Tata Steel, SRF may gain from weaker currency? Experts explain
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Valiant Organics among 5 commodity stocks that hit 52-week highs and rallied up to 48% in a month